Navigation Links
NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS
Date:5/31/2008

Two Phase II studies demonstrated potential for pazopanib as a single agent treatment for early stage non-small cell lung cancer and advanced renal cell cancer:

-- In patients with stage I-III non-small cell lung cancer, 86 percent of

patients who received pazopanib monotherapy experienced a reduction in

tumor volume

-- In patients with advanced renal cell cancer, there was an overall

response rate of 35 percent. The median duration of response was longer

than 16 months (68 weeks) and the median progression-free survival was

11.9 months

LONDON and PHILADELPHIA, May 31 /PRNewswire-USNewswire/ -- GlaxoSmithKline today announced the results of two Phase II trials demonstrating the potential for pazopanib, an oral, investigational angiogenesis inhibitor, as a treatment for non-small cell lung cancer (NSCLC),(1) the most common form of lung cancer,(2) and renal cell carcinoma (RCC).(3) The data were presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Pazopanib is not approved in any market for any indication at this time.

Pazopanib targets vascular endothelial growth factor receptor (VEGFR), platelet derived growth factor receptor (PDGFR) and c-kit, key proteins that help with the growth of new blood vessels in the body.(4) This process, known as angiogenesis, plays a critical role in the growth and spread of tumors(5).

"These very promising results highlight the potential of pazopanib as a future treatment option across multiple forms of cancer," said Thierry Le Chevalier, M.D., Vice President, Oncology Medicine Development Center, GSK. "GSK is conducting a broad research program for pazopanib in a number of tumor types and this demonstrates our ongoing commitment to the development of innovative and effective treatments for patients with cancer."

Pazopanib and Non-Small Cell Lung Cancer: abstract 7557 (1)

DATA
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
2. Scientists, physicians present latest findings in personalized cancer treatment and prevention
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Health psychologists discuss latest research findings
5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
6. PA Governor Rendell Announces Latest Nominations and Appointments
7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
9. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
11. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... MO (PRWEB) , ... September 01, 2015 , ... ... Wednesday, September 9, 2015 from 5:00 to 8:00 pm at the Marriott Indianapolis ... and groups with career opportunities will be attending from across the country. All ...
(Date:9/1/2015)... ... 01, 2015 , ... Dr. Trace Curry successfully placed one of the first ... last month the FDA has approved two intra-gastric balloons, the ORBERA ™ Managed ... first incisionless, reversible, weight loss procedures available to Americans. , Dr. Curry, ...
(Date:9/1/2015)... ... ... Elizabeth Callahan, MD, founder and medical director of SkinSmart Dermatology® , is ... treatment for volume loss in the hands. RADIESSE provides an immediate volumizing effect and ... smooth, natural-looking results that can last up to one year in most patients. Treating ...
(Date:9/1/2015)... ... ... September is Baby Safety Month, and Lightning Labels wants to ... ones' safety top of mind at all times. , Sponsored by the Juvenile Products ... JPMA's Baby Safety Zone website, this year's theme is A Room with A Safe ...
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry is an organized system ... therapy patients. The Registry is being developed by the American Physical Therapy Association (APTA). ... to be selected to contribute FOTO Outcomes measures as one of the primary global ...
Breaking Medicine News(10 mins):Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2
... ... available on XM Satellite Radio Channel 160. This program is produced by KarenZupko & ... ReachMD, a new media communications platform for medical professionals. , ... Chicago, IL (PRWEB) July 15, 2009 ...
... ... the third fastest growing private company by the Indianapolis Business Journal. Mainstreet is a ... since 2006, and from 4 to 145 employees. , ... Cicero, IN (PRWEB) July 15, 2009 -- Mainstreet Property Group ...
... ... application backlogs rise, the impact on people with disabilities grows and adds to financial ... Belleville, ... rate in nine months, according to a quarterly study by Allsup , a ...
... , , , ... in "International Immunopharmacology," reveals why Pycnogenol(R) (pic-noj-en-all), an antioxidant plant ... is effective for reducing inflammation and soothing pain associated with ... Research Institute on Food and Nutrition in Rome, Italy, found ...
... , SAN DIEGO, July 14 CareFusion ... Cardinal Health,s clinical and medical products businesses, today announced the pricing ... notes. The notes consist of the following tranches: , ... principal amount of 4.125% senior notes due 2012 , ...
... , , State must comply - NOT ... OAKLAND, Calif., July 14 In a ruling issued late yesterday ... her June 25, 2009, ruling which halts the State,s plans to cut In-Home ... ruling sends a clear message to the Governor that you can,t ignore the ...
Cached Medicine News:Health News:KarenZupko & Associates, Inc. and ReachMD XM 160 Announce New Radio Programming Series, "Practice Success" hosted by Karen Zupko 2Health News:KarenZupko & Associates, Inc. and ReachMD XM 160 Announce New Radio Programming Series, "Practice Success" hosted by Karen Zupko 3Health News:Growth Despite Economy; Mainstreet Property Group Named One of Indiana's Fastest Growing Companies 2Health News:Growth Despite Economy; Mainstreet Property Group Named One of Indiana's Fastest Growing Companies 3Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 2Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 3Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 4Health News:Income at Risk: Unemployment Reaches Nine-Month High for Those with Disabilities, Reports Allsup 5Health News:Study Demonstrates the Anti-Inflammatory Properties of Pine Bark Extract on Inflammatory Mediators COX-2 and 5-LOX 2Health News:Study Demonstrates the Anti-Inflammatory Properties of Pine Bark Extract on Inflammatory Mediators COX-2 and 5-LOX 3Health News:CareFusion Prices $1.4 Billion of Senior Notes 2Health News:Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 2
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
(Date:8/31/2015)... PLEASANTON, Calif. , Aug. 31, 2015  QT Vascular ... "QT Vascular", and together with its subsidiaries, the ... assembly and distribution of advanced therapeutic solutions for ... today the final results of the below-the-knee ("BTK") ... Registry ("BAR") which were presented on August 15, ...
(Date:8/31/2015)... Aug. 31, 2015   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell ... cryopreservation freeze media and a related ... for smart shippers ("BioLife" or the ... an advanced biopharmaceutical company focused on developing and ...
Breaking Medicine Technology:Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... Va., Feb. 9, 2011 With generous funding ... Palliative Care Association are partnering to improve pain ... hospitals in The Gambia, Kenya, and Malawi. ... they each have well-established national palliative care organizations, ...
... Design Trends: Technological Advances in Implantable Devices, a UBM Canon Medical Device ... Industry ( MD+DI ) , ... , and OrthoTec , is now on-demand ... 1,092, with an attendance of 50% during the live event held on ...
Cached Medicine Technology:FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi 2Now Available: Archived Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 2Now Available: Archived Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: